20150706 Guggenheim Securities 降级, 评级:中性->卖出,
更多分析和资讯,请关注微-信-公-众-号 stock_tong查看全文
$Aegerion制药(AEGR)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2016-10-06 AccNo: 0001047469-16-015996 Size: 3 MB 网页链接
$Aegerion制药(AEGR)$ 8-K - Current report Filed: 2016-10-03 AccNo: 0001104659-16-148221 Size: 56 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Aegerion制药(AEGR)$ 内部交易: 2016-09-13,10% Owner,Broadfin Healthcare Master Fun ,买入,75000普通股, $1.75
$Aegerion制药(AEGR)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-09-13 AccNo: 0000919574-16-015351 Size: 102 KB 网页链接
$Aegerion制药(AEGR)$ 内部交易: 2016-09-12,10% Owner,Broadfin Healthcare Master Fun ,买入,176000普通股, $1.70
$Aegerion制药(AEGR)$ 内部交易: 2016-09-09,10% Owner,Broadfin Healthcare Master Fun ,买入,100000普通股, $1.60
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-09-12 AccNo: 0001104659-16-144223 Size: 124 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-08-10 AccNo: 0001104659-16-138636 Size: 858 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-08-09 AccNo: 0001558370-16-007808 Size: 375 KB 网页链接
$Aegerion制药(AEGR)$ 8-K - Current report Filed: 2016-08-09 AccNo: 0001558370-16-007798 Size: 418 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接